Albert Chonyang L, Kamdar Forum, Hanna Mazen
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Curr Heart Fail Rep. 2016 Oct;13(5):197-206. doi: 10.1007/s11897-016-0302-z.
Digoxin remains one of the oldest therapies for heart failure; however, its safety and efficacy have been controversial since its initial use. Questions that remain include the clinical efficacy of digoxin when added to contemporary medical therapy, when and if it should be added, and how to minimize adverse effects. In this review, we will summarize recent data on the use of digoxin in systolic heart failure and address some of the controversies regarding the role of digoxin in the modern era of heart failure treatment.
地高辛仍然是治疗心力衰竭最古老的疗法之一;然而,自其首次使用以来,其安全性和有效性一直存在争议。仍然存在的问题包括地高辛添加到当代药物治疗中的临床疗效、何时以及是否应添加,以及如何将不良反应降至最低。在本综述中,我们将总结地高辛在收缩性心力衰竭中应用的最新数据,并探讨地高辛在现代心力衰竭治疗中作用的一些争议。